{"id":"rozerem-ramelteon","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"},{"rate":"10-20%","effect":"Dizziness"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Somnolence"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By activating melatonin receptors, Ramelteon helps to increase the levels of melatonin in the brain, promoting sleepiness and reducing wakefulness. This action is thought to be mediated through the MT1 and MT2 receptors, which are involved in regulating the sleep-wake cycle. Activation of these receptors leads to a decrease in the activity of neurons that promote wakefulness and an increase in the activity of neurons that promote sleepiness.","oneSentence":"Rozerem (Ramelteon) is a melatonin receptor agonist that binds to melatonin receptors MT1 and MT2, mimicking the action of melatonin to regulate sleep-wake cycles.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:32:54.396Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Insomnia characterized by difficulties with sleep initiation"}]},"trialDetails":[{"nctId":"NCT07382843","phase":"PHASE4","title":"Melatonin Agonist for Shift-time Workers.","status":"COMPLETED","sponsor":"Tri-Service General Hospital","startDate":"2024-03-04","conditions":"Circadian Rhythm Disorders","enrollment":61},{"nctId":"NCT06890715","phase":"PHASE1","title":"Comparative Pharmacokinetic Study of Ramelteon Modified-Release Tablets and Ramelteon Tablets in Healthy Subjects","status":"COMPLETED","sponsor":"Overseas Pharmaceuticals, Ltd.","startDate":"2024-06-24","conditions":"Chronic Insomnia Characterized","enrollment":12},{"nctId":"NCT03461042","phase":"PHASE4","title":"The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic Insomnia","status":"COMPLETED","sponsor":"Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan","startDate":"2018-02-06","conditions":"Chronic Insomnia","enrollment":17},{"nctId":"NCT05069428","phase":"PHASE4","title":"Delirium Reduction With Ramelteon","status":"RECRUITING","sponsor":"Centennial Medical Center","startDate":"2023-03-26","conditions":"Delirium","enrollment":506},{"nctId":"NCT06512363","phase":"PHASE3","title":"A Study of Ramelteon in Chinese Patients With Chronic Insomnia","status":"NOT_YET_RECRUITING","sponsor":"Nanjing Chia-tai Tianqing Pharmaceutical","startDate":"2024-08","conditions":"Chronic Insomnia","enrollment":280},{"nctId":"NCT03931070","phase":"PHASE4","title":"The Effect of Ramelteon on Delirium and Sleep in Patients Admitted to the ICU","status":"COMPLETED","sponsor":"Rhode Island Hospital","startDate":"2019-05-09","conditions":"Delirium","enrollment":112},{"nctId":"NCT00745030","phase":"NA","title":"Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2008-06","conditions":"REM Behavior Disorder, Parkinsonism","enrollment":3},{"nctId":"NCT01048242","phase":"PHASE3","title":"Treatment of Insomnia in Elderly Sleep Apnea Patients With Ramelteon (TAK 375)","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2006-07","conditions":"Insomnia, Obstructive Sleep Apnea","enrollment":27},{"nctId":"NCT05414864","phase":"PHASE4","title":"Insomnia Prevalence and Treatment Impact on Systemic Hypertension","status":"TERMINATED","sponsor":"University of Sao Paulo","startDate":"2022-05-01","conditions":"Insomnia, Hypertension","enrollment":5},{"nctId":"NCT03432091","phase":"","title":"Melatonin Receptor Agonist and Peripheral Biological Markers","status":"COMPLETED","sponsor":"National Science and Technology Council, Taiwan","startDate":"2016-01-11","conditions":"Insomnia","enrollment":40},{"nctId":"NCT02691013","phase":"NA","title":"The Impact of Ramelteon on Sleep and Delirium in Patients Who Undergo Pulmonary Thromboendarterectomy (PTE) Surgery","status":"UNKNOWN","sponsor":"University of California, San Diego","startDate":"2016-02","conditions":"Delirium, Sleep Deprivation","enrollment":120},{"nctId":"NCT03265951","phase":"PHASE4","title":"Ramelteon for Complex Insomnia in Veterans With PTSD","status":"WITHDRAWN","sponsor":"State University of New York at Buffalo","startDate":"2018-01-01","conditions":"Insomnia","enrollment":""},{"nctId":"NCT03091738","phase":"PHASE4","title":"Ramelteon for Treatment of Insomnia in Cirrhosis","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2017-02-01","conditions":"Cirrhosis","enrollment":10},{"nctId":"NCT04470297","phase":"PHASE2","title":"Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19","status":"UNKNOWN","sponsor":"Associação Fundo de Incentivo à Pesquisa","startDate":"2020-09","conditions":"Covid19, Lung Injury","enrollment":100},{"nctId":"NCT02324153","phase":"PHASE2","title":"Ramelteon in the Prevention of Post-operative Delirium","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2017-03-24","conditions":"Delirium, Delirium, Dementia, Amnestic, Cognitive Disorders, Delayed Emergence From Anesthesia","enrollment":80},{"nctId":"NCT03165695","phase":"PHASE4","title":"Ramelteon vs Placebo for Prevention of Delirium and Improvement of Sleep in Hospitalized Older Adults","status":"WITHDRAWN","sponsor":"Brigham and Women's Hospital","startDate":"2019-12-01","conditions":"Delirium in Old Age","enrollment":""},{"nctId":"NCT02560324","phase":"PHASE2","title":"Effect of Ramelteon on Smoking Abstinence","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2015-09","conditions":"Tobacco Use Disorder","enrollment":140},{"nctId":"NCT00642694","phase":"PHASE3","title":"Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon","status":"TERMINATED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2007-05","conditions":"Major Depressive Disorder, Insomnia","enrollment":29},{"nctId":"NCT02669082","phase":"PHASE4","title":"The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy","status":"COMPLETED","sponsor":"Takeda","startDate":"2017-05-09","conditions":"Insomnia, Major Depressive Disorder","enrollment":26},{"nctId":"NCT03075657","phase":"PHASE4","title":"Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia","status":"COMPLETED","sponsor":"All India Institute of Medical Sciences, Bhubaneswar","startDate":"2017-05-01","conditions":"Schizophrenia","enrollment":120},{"nctId":"NCT02564939","phase":"PHASE4","title":"Ramelteon Prevention of Delirium - RCT","status":"UNKNOWN","sponsor":"Hartford Hospital","startDate":"2017-02-23","conditions":"Delirium","enrollment":240},{"nctId":"NCT00746239","phase":"NA","title":"Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for Anxiety","status":"TERMINATED","sponsor":"Milton S. Hershey Medical Center","startDate":"2008-08","conditions":"Panic Disorder, Insomnia","enrollment":11},{"nctId":"NCT02840591","phase":"PHASE4","title":"Ramelteon and Citicoline for Delirium","status":"WITHDRAWN","sponsor":"University of Texas Southwestern Medical Center","startDate":"2016-07","conditions":"Delirium","enrollment":""},{"nctId":"NCT00325728","phase":"PHASE2","title":"Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease","status":"COMPLETED","sponsor":"Takeda","startDate":"2006-03-21","conditions":"Chronic Insomnia","enrollment":74},{"nctId":"NCT00753623","phase":"NA","title":"Clinical Management of Neuropathic Pain With Ramelteon","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2008-09","conditions":"Neuropathic Pain","enrollment":23},{"nctId":"NCT02153086","phase":"","title":"Ramelteon 8 mg Tablets Specified Drug-use Survey: <Long-term Survey on Insomnia Accompanied by Difficulty Falling Asleep> - Transitional Survey From the Preceding Drug-use Survey -","status":"COMPLETED","sponsor":"Takeda","startDate":"2011-03","conditions":"Insomnia","enrollment":236},{"nctId":"NCT00539110","phase":"PHASE2","title":"Differential Effects of Zolpidem Versus Ramelteon in Burned Children","status":"COMPLETED","sponsor":"Shriners Hospitals for Children","startDate":"2009-12","conditions":"Sleep, Burns","enrollment":10},{"nctId":"NCT02058992","phase":"","title":"Ramelteon Tablets 8mg Drug Use Surveillance: Survey on Insomnia Associated With Sleep-onset Difficulty","status":"COMPLETED","sponsor":"Takeda","startDate":"2010-07","conditions":"Insomnia","enrollment":3339},{"nctId":"NCT00414102","phase":"PHASE4","title":"Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.","status":"COMPLETED","sponsor":"Takeda","startDate":"2006-10","conditions":"Chronic Insomnia","enrollment":552},{"nctId":"NCT01467713","phase":"PHASE3","title":"Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder","status":"TERMINATED","sponsor":"Takeda","startDate":"2011-12","conditions":"Bipolar Disorder","enrollment":642},{"nctId":"NCT01467700","phase":"PHASE3","title":"Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder","status":"TERMINATED","sponsor":"Takeda","startDate":"2011-12","conditions":"Acute Depressive Episode","enrollment":490},{"nctId":"NCT01677182","phase":"PHASE3","title":"Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder","status":"TERMINATED","sponsor":"Takeda","startDate":"2012-08","conditions":"Bipolar Disorder","enrollment":535},{"nctId":"NCT02156271","phase":"PHASE4","title":"Mechanisms of Sleep Latency and Health: The Effect of a Melatonin Receptor Agonist in Inflammation and Insulin Resistance","status":"COMPLETED","sponsor":"Duke University","startDate":"2007-07","conditions":"Insomnia","enrollment":75},{"nctId":"NCT01207050","phase":"PHASE4","title":"Effect of Rozerem on Sleep Among People With Traumatic Brain Injury","status":"UNKNOWN","sponsor":"Kessler Foundation","startDate":"2010-09","conditions":"Insomnia, Brain Injury","enrollment":20},{"nctId":"NCT00576927","phase":"PHASE4","title":"Improving Sleep in Nursing Homes","status":"COMPLETED","sponsor":"Emory University","startDate":"2007-10","conditions":"Sleep Deprivation","enrollment":79},{"nctId":"NCT00507546","phase":"PHASE4","title":"Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia","status":"COMPLETED","sponsor":"US Department of Veterans Affairs","startDate":"2007-07","conditions":"Insomnia, Spinal Cord Injury, Tetraplegia","enrollment":12},{"nctId":"NCT00552760","phase":"PHASE4","title":"Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder","status":"COMPLETED","sponsor":"Lehigh Valley Hospital","startDate":"2007-11","conditions":"Bipolar Disorder","enrollment":90},{"nctId":"NCT00893269","phase":"PHASE1","title":"The Effect of Marijuana and Prescription Medications in Mood, Performance and Sleep","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2008-10","conditions":"Marijuana Dependence","enrollment":36},{"nctId":"NCT00811746","phase":"NA","title":"Hypnotics to Improve Polysomnography Yield: Eszopiclone vs Ramelteon?","status":"COMPLETED","sponsor":"Southern California Institute for Research and Education","startDate":"2008-12","conditions":"Obstructive Sleep Apnea","enrollment":90},{"nctId":"NCT00622427","phase":"PHASE4","title":"Ramelteon for Treatment of Adult Patients With ADHD-Related Insomnia","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2008-02","conditions":"ADHD With Sleep Onset Insomnia","enrollment":32},{"nctId":"NCT00585208","phase":"PHASE3","title":"Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance","status":"TERMINATED","sponsor":"Lindner Center of HOPE","startDate":"2007-12","conditions":"Insomnia, Bipolar Disorder","enrollment":21},{"nctId":"NCT00869167","phase":"PHASE3","title":"Ramelteon for Insomnia Comorbid With Asthma","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2008-03","conditions":"Insomnia, Asthma","enrollment":2},{"nctId":"NCT01685151","phase":"PHASE3","title":"A Safety and Efficacy Study of Ramelteon Tablets for Sublingual Administration (TAK-375SL) in the Maintenance Treatment of Bipolar 1 Disorder","status":"WITHDRAWN","sponsor":"Takeda","startDate":"2012-09","conditions":"Bipolar Disorder","enrollment":""},{"nctId":"NCT00671567","phase":"PHASE3","title":"Ramelteon in Adults With Chronic Insomnia","status":"COMPLETED","sponsor":"Takeda","startDate":"2002-12","conditions":"Chronic Insomnia","enrollment":848},{"nctId":"NCT00671125","phase":"PHASE3","title":"Study of Efficacy of Ramelteon in Adults With Chronic Insomnia","status":"COMPLETED","sponsor":"Takeda","startDate":"2003-01","conditions":"Chronic Insomnia","enrollment":405},{"nctId":"NCT00907595","phase":"NA","title":"Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2009-05","conditions":"Huntington's Disease, Parkinson's Disease, Dementia With Lewy Bodies","enrollment":""},{"nctId":"NCT00595075","phase":"NA","title":"Ramelteon for a Nap Prior to a Night Shift","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2007-12","conditions":"Healthy","enrollment":11},{"nctId":"NCT00595504","phase":"PHASE4","title":"Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2008-01","conditions":"Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders","enrollment":25},{"nctId":"NCT00739024","phase":"PHASE2","title":"A Study of a Melatonin Receptor Agonist to Prevent Migraine","status":"TERMINATED","sponsor":"Swedish Medical Center","startDate":"2008-04","conditions":"Migraine, Migraine With Aura, Migraine Without Aura","enrollment":18},{"nctId":"NCT00914862","phase":"PHASE1","title":"Pharmacokinetic and Safety of Ramelteon Between Adolescents With Insomnia and Healthy Adults","status":"COMPLETED","sponsor":"Takeda","startDate":"2009-11","conditions":"Insomnia","enrollment":56},{"nctId":"NCT00568789","phase":"PHASE4","title":"Safety of Ramelteon in Elderly Subjects","status":"COMPLETED","sponsor":"Takeda","startDate":"2006-06","conditions":"Insomnia","enrollment":33},{"nctId":"NCT00671086","phase":"PHASE3","title":"Efficacy of Ramelteon in Subjects With Chronic Insomnia","status":"COMPLETED","sponsor":"Takeda","startDate":"2003-02","conditions":"Sleep Initiation and Maintenance Disorders","enrollment":1213},{"nctId":"NCT00755508","phase":"PHASE2","title":"Efficacy and Safety of Ramelteon Combined With Gabapentin in Treating Patients With Insomnia","status":"COMPLETED","sponsor":"Takeda","startDate":"2005-11","conditions":"Sleep Initiation and Maintenance Disorders","enrollment":378},{"nctId":"NCT00671398","phase":"PHASE3","title":"Efficacy of Ramelteon on Transient Insomnia in Healthy Adults","status":"COMPLETED","sponsor":"Takeda","startDate":"2002-12","conditions":"Transient Insomnia","enrollment":289},{"nctId":"NCT00672724","phase":"PHASE3","title":"Efficacy of Ramelteon in Adults With Chronic Insomnia","status":"TERMINATED","sponsor":"Takeda","startDate":"2005-02","conditions":"Chronic Insomnia","enrollment":1081},{"nctId":"NCT00656994","phase":"PHASE3","title":"Long-Term Efficacy of Ramelteon on Endocrine Function in Adult Subjects With Chronic Insomnia","status":"COMPLETED","sponsor":"Takeda","startDate":"2003-01","conditions":"Insomnia","enrollment":122},{"nctId":"NCT00492011","phase":"PHASE4","title":"Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"Takeda","startDate":"2007-02","conditions":"Circadian Dysregulation","enrollment":110},{"nctId":"NCT00671190","phase":"PHASE2","title":"Safety and Efficacy of Ramelteon in Healthy Subjects","status":"COMPLETED","sponsor":"Takeda","startDate":"2005-03","conditions":"Sleep Disorder","enrollment":75},{"nctId":"NCT00755495","phase":"PHASE2","title":"Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic Insomnia","status":"COMPLETED","sponsor":"Takeda","startDate":"2006-07","conditions":"Sleep Initiation and Maintenance Disorders","enrollment":472},{"nctId":"NCT00672802","phase":"PHASE2","title":"Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Takeda","startDate":"2003-08","conditions":"Chronic Obstructive Pulmonary Disease, COPD","enrollment":26},{"nctId":"NCT00671294","phase":"PHASE3","title":"Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia.","status":"COMPLETED","sponsor":"Takeda","startDate":"2002-10","conditions":"Chronic Insomnia","enrollment":100},{"nctId":"NCT00671632","phase":"PHASE2","title":"Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse","status":"COMPLETED","sponsor":"Takeda","startDate":"2003-06","conditions":"Drug Abuse","enrollment":14},{"nctId":"NCT00671255","phase":"PHASE3","title":"Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia","status":"COMPLETED","sponsor":"Takeda","startDate":"2002-12","conditions":"Chronic Insomnia","enrollment":829},{"nctId":"NCT00593736","phase":"PHASE2","title":"Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase Syndrome","status":"COMPLETED","sponsor":"Takeda","startDate":"2007-10","conditions":"Sleep Disorders, Circadian Rhythm","enrollment":132},{"nctId":"NCT00672061","phase":"PHASE2","title":"Safety of Ramelteon in Subjects With Mild to Moderate Obstructive Sleep Apnea","status":"COMPLETED","sponsor":"Takeda","startDate":"2003-07","conditions":"Sleep Apnea, Obstructive","enrollment":26},{"nctId":"NCT00391755","phase":"PHASE4","title":"A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches","status":"TERMINATED","sponsor":"Charlottesville Neuroscience","startDate":"2006-10","conditions":"Migraine Headache","enrollment":4},{"nctId":"NCT00237497","phase":"PHASE3","title":"Safety and Efficacy of Ramelteon in Adults With Chronic Insomnia","status":"COMPLETED","sponsor":"Takeda","startDate":"2005-07","conditions":"Balance","enrollment":275},{"nctId":"NCT00337272","phase":"PHASE4","title":"Treating Chronic Insomnia in Breast Cancer Patients","status":"TERMINATED","sponsor":"Accelerated Community Oncology Research Network","startDate":"2006-08","conditions":"Chronic Insomnia","enrollment":16},{"nctId":"NCT01401413","phase":"PHASE4","title":"Study to Determine Whether Ramelteon Helps People With REM Sleep Behavior Disorder","status":"COMPLETED","sponsor":"Sleep Medicine Centers of WNY","startDate":"2008-01","conditions":"REM Sleep Behavior Disorder","enrollment":20},{"nctId":"NCT01128582","phase":"PHASE3","title":"Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia.","status":"UNKNOWN","sponsor":"Southern Arizona VA Health Care System","startDate":"2009-03","conditions":"Gastroesophageal Reflux Disease, Chronic Insomnia","enrollment":40},{"nctId":"NCT00462254","phase":"PHASE4","title":"Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease","status":"TERMINATED","sponsor":"Southern California Institute for Research and Education","startDate":"2007-06","conditions":"Parkinson's Disease","enrollment":4},{"nctId":"NCT01180855","phase":"PHASE4","title":"Effects of Ramelteon (8mg) Alone and in Combination With Multi-Component Behavioral Therapy on Sleep and Circadian Phase in Patients With Chronic Insomnia","status":"UNKNOWN","sponsor":"University of Arizona","startDate":"2007-08","conditions":"Insomnia","enrollment":30},{"nctId":"NCT00492232","phase":"PHASE4","title":"Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia","status":"COMPLETED","sponsor":"Takeda","startDate":"2007-04","conditions":"Chronic Insomnia","enrollment":135},{"nctId":"NCT00247390","phase":"PHASE3","title":"Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.","status":"COMPLETED","sponsor":"Takeda","startDate":"2005-07","conditions":"Chronic Insomnia","enrollment":451},{"nctId":"NCT00316992","phase":"PHASE4","title":"Safety of Ramelteon in Subjects With Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Takeda","startDate":"2006-04","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":25},{"nctId":"NCT00915135","phase":"PHASE2","title":"Efficacy and Safety of Ramelteon on Chronic Insomnia","status":"COMPLETED","sponsor":"Takeda","startDate":"2002-05","conditions":"Chronic Insomnia","enrollment":66},{"nctId":"NCT00756002","phase":"PHASE3","title":"Safety and Efficacy Study of Ramelteon in Subjects With Chronic Insomnia","status":"COMPLETED","sponsor":"Takeda","startDate":"2007-08","conditions":"Sleep Initiation and Maintenance Disorders","enrollment":259},{"nctId":"NCT00502320","phase":"PHASE4","title":"Ramelteon in the Treatment of Sleep and Mood in Patients With Seasonal Affective Disorder","status":"COMPLETED","sponsor":"Lehigh Valley Hospital","startDate":"2006-09","conditions":"Seasonal Affective Disorder","enrollment":50},{"nctId":"NCT00319215","phase":"PHASE1","title":"Effects of Ramelteon on Driving Ability","status":"COMPLETED","sponsor":"Utrecht Institute for Pharmaceutical Sciences","startDate":"2006-03","conditions":"Insomnia","enrollment":30}],"_emaApprovals":[],"_faersSignals":[{"count":3,"reaction":"NAUSEA"},{"count":3,"reaction":"RENAL FAILURE ACUTE"},{"count":2,"reaction":"ALTERED STATE OF CONSCIOUSNESS"},{"count":2,"reaction":"ASTHENIA"},{"count":2,"reaction":"BACK PAIN"},{"count":2,"reaction":"CONDITION AGGRAVATED"},{"count":2,"reaction":"DIARRHOEA"},{"count":2,"reaction":"DIZZINESS"},{"count":2,"reaction":"FALL"},{"count":2,"reaction":"HYPERTENSION"}],"_approvalHistory":[],"publicationCount":564,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ramelteon","Rozerem","ramelteon"],"phase":"phase_3","status":"active","brandName":"Rozerem (Ramelteon)","genericName":"Rozerem (Ramelteon)","companyName":"Southern California Institute for Research and Education","companyId":"southern-california-institute-for-research-and-education","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ramelteon, also known as Rozerem, is a small molecule that acts as a melatonin receptor agonist. It is used to treat conditions such as insomnia and sleep initiation and maintenance disorders.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}